Browse our anti-BCL10 (BCL10) Antibodies

Full name:
anti-B-Cell CLL/lymphoma 10 Antibodies (BCL10)
On are 303 B-Cell CLL/lymphoma 10 (BCL10) Antibodies from 30 different suppliers available. Additionally we are shipping BCL10 Kits (23) and BCL10 Proteins (12) and many more products for this protein. A total of 342 BCL10 products are currently listed.
AI132454, BCL-10, bcl10, c-E10, C81403, CARMEN, cE10, CIPER, CLAP, ME10
list all antibodies Gene Name GeneID UniProt
BCL10 8915 O95999
BCL10 83477 Q9QYN5
BCL10 12042 Q9Z0H7

Show all species

Show all synonyms

Most Popular Reactivities for anti-BCL10 (BCL10) Antibodies

Select your species and application

anti-Human BCL10 Antibodies:

anti-Rat (Rattus) BCL10 Antibodies:

anti-Mouse (Murine) BCL10 Antibodies:

All available anti-BCL10 Antibodies

Go to our pre-filtered search.

Top referenced anti-BCL10 Antibodies

  1. Human Polyclonal BCL10 Primary Antibody for WB - ABIN264992 : Zhang, Siebert, Yan, Hinzmann, Cui, Xue, Rakestraw, Naeve, Beckmann, Weisenburger, Sanger, Nowotny, Vesely, Callet-Bauchu, Salles, Dixit, Rosenthal, Schlegelberger, Morris: Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). in Nature genetics 1999 (PubMed)
    Show all 6 references for 264992

  2. Human Polyclonal BCL10 Primary Antibody for EIA, FACS - ABIN950621 : Bhattacharyya, Borthakur, Dudeja, Tobacman: Lipopolysaccharide-induced activation of NF-κB non-canonical pathway requires BCL10 serine 138 and NIK phosphorylations. in Experimental cell research 2010 (PubMed)
    Show all 5 references for 950621

  3. Human Monoclonal BCL10 Primary Antibody for IHC (p), IHC - ABIN269575 : Ye, Dogan, Karran, Willis, Chen, Wlodarska, Dyer, Isaacson, Du: BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma. in The American journal of pathology 2000 (PubMed)
    Show all 5 references for 269575

  4. Human Monoclonal BCL10 Primary Antibody for WB - ABIN1944800 : Koseki, Inohara, Chen, Carrio, Merino, Hottiger, Nabel, Núñez: CIPER, a novel NF kappaB-activating protein containing a caspase recruitment domain with homology to Herpesvirus-2 protein E10. in The Journal of biological chemistry 1999 (PubMed)
    Show all 4 references for 1944800

  5. Human Monoclonal BCL10 Primary Antibody for ICC, FACS - ABIN1724629 : Willis, Jadayel, Du, Peng, Perry, Abdul-Rauf, Price, Karran, Majekodunmi, Wlodarska, Pan, Crook, Hamoudi, Isaacson, Dyer: Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. in Cell 1999 (PubMed)
    Show all 3 references for 1724629

  6. Human Polyclonal BCL10 Primary Antibody for WB - ABIN153020 : Nagy, Rui, Stepkowski, Karras, Kirken: A preferential role for STAT5, not constitutively active STAT3, in promoting survival of a human lymphoid tumor. in Journal of immunology (Baltimore, Md. : 1950) 2006 (PubMed)

  7. Human Polyclonal BCL10 Primary Antibody for FACS, IF - ABIN654655 : Bhattacharyya, Borthakur, Tyagi, Gill, Chen, Dudeja, Tobacman: B-cell CLL/lymphoma 10 (BCL10) is required for NF-kappaB production by both canonical and noncanonical pathways and for NF-kappaB-inducing kinase (NIK) phosphorylation. in The Journal of biological chemistry 2009 (PubMed)

More Antibodies against BCL10 Interaction Partners

Mouse (Murine) B-Cell CLL/lymphoma 10 (BCL10) interaction partners

  1. Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic immunity.

  2. cell receptor-dependent activation of mTOR signaling in T cells is mediated by Carma1 and MALT1, but not Bcl10.

  3. Trehalose 6,6'-dimycolate-induced Mincle (show CLEC4E Antibodies) expression is dependent on Dectin-3-mediated NF-kappaB (show NFKB1 Antibodies) activation through the CARD9 (show CARD9 Antibodies)-BCL10-MALT1 (show MALT1 Antibodies) complex.

  4. Bcl10 mediates angiotensin II-induced cardiac damage and electrical remodeling.

  5. TCR-stimulated activation of NF-kappaB requires the assembly of cytosolic p62-Bcl10-Malt1-IKK signalosomes, which may ensure highly regulated activation of NF-kappaB in response to TCR engagement.

  6. Bcl10 is an essential regulator for A20 (show TNFAIP3 Antibodies) gene expression.

  7. Data indicate that caspase recruitment domain-containing protein 11 (CARD11 (show CARD11 Antibodies)) is involved in the pathogenesis of collagen-induced arthritis (CIA (show NCOA5 Antibodies)) by formation of the CARD11 (show CARD11 Antibodies)/Bcl10 complex and enhancement of the Th17 cell response.

  8. Findings demonstrate a Bcl10 requirement for maximum development of carrageenan-induced inflammation and lack of complete suppression by IL-10 (show IL10 Antibodies) of carrageenan-induced inflammation.

  9. Bcl10 links saturated fat overnutrition with hepatocellular NF-kB activation and insulin (show INS Antibodies) resistance.

  10. identify Bcl10 as an early coordinator of NF-kappaB-mediated immune response with endosomal trafficking and signaling to F-actin remodeling

Human B-Cell CLL/lymphoma 10 (BCL10) interaction partners

  1. results define molecular determinants that control the production of Lin(Ub)n-Bcl10, an important signaling intermediate in TCR and oncogenic CARD11 (show CARD11 Antibodies) signaling.

  2. Psoriasis mutations disrupt CARD14 (show CARD14 Antibodies) autoinhibition promoting BCL10-MALT1 (show MALT1 Antibodies)-dependent NF-kappaB (show NFKB1 Antibodies) activation

  3. BCL10 promoted DNA double-strand breaks repair, enhancing cell survival after DNA damage.

  4. Data show that caspase recruitment domain-containing protein 11 (show CARD11 Antibodies)/B-cell CLL/lymphoma 10/mucosa-associated lymphoid tissue lymphoma translocation gene 1 (show MALT1 Antibodies) signaling drives lymphoproliferation (show FAS Antibodies) through NF-kappa B (show NFKB1 Antibodies) and c-Jun N-terminal kinase activation.

  5. BCL10 is not essential for actin polymerization after fibroblast FcgammaR stimulation.

  6. characterization of zebrafish (Danio rerio) Bcl10

  7. we identified BCL10 as a bona fide target of BCR (show BCR Antibodies)-induced linear ubiquitylation and demonstrated an important role of the linear ubiquitin ligase HOIP (show RNF31 Antibodies) in BCR (show BCR Antibodies)-induced phosphorylation

  8. The results of this study indicate that inherited BCL10 deficiency should be considered in patients with combined immunodeficiency with B cell, T cell, and fibroblast defects.

  9. B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1 (show STAT1 Antibodies)/ATF4 (show ATF4 Antibodies)/S100P (show S100P Antibodies) signaling pathway.

  10. BCL10 induces cleavage of MALT1 (show MALT1 Antibodies) at R149 in 293T cells.

Pig (Porcine) B-Cell CLL/lymphoma 10 (BCL10) interaction partners

  1. Data show that BCL10 was located in cytoplasm in Pig Kidney Epithelial (PK15) cells.

  2. Data found that, BCL10 expressed in high level in swine spleen, and with a modest level in thymus, brain and lymph node; low level mRNA was expressed in liver and not detectable level in kidney.

BCL10 Antigen Profile

Antigen Summary

This gene was identified by its translocation in a case of mucosa-associated lymphoid tissue (MALT) lymphoma. The protein encoded by this gene contains a caspase recruitment domain (CARD), and has been shown to induce apoptosis and to activate NF-kappaB. This protein is reported to interact with other CARD domain containing proteins including CARD9, 10, 11 and 14, which are thought to function as upstream regulators in NF-kappaB signaling. This protein is found to form a complex with MALT1, a protein encoded by another gene known to be translocated in MALT lymphoma. MALT1 and this protein are thought to synergize in the activation of NF-kappaB, and the deregulation of either of them may contribute to the same pathogenetic process that leads to the malignancy.

Alternative names and synonyms associated with BCL10

  • B-cell CLL/lymphoma 10 (BCL10) antibody
  • B-cell CLL/lymphoma 10 (Bcl10) antibody
  • B-cell CLL/lymphoma 10 (bcl10) antibody
  • B-cell CLL/lymphoma 10 (LOC100223183) antibody
  • B cell leukemia/lymphoma 10 (Bcl10) antibody
  • B-cell lymphoma/leukemia 10 (bcl10) antibody
  • AI132454 antibody
  • BCL-10 antibody
  • bcl10 antibody
  • c-E10 antibody
  • C81403 antibody
  • CARMEN antibody
  • cE10 antibody
  • CIPER antibody
  • CLAP antibody
  • ME10 antibody

Protein level used designations for BCL10

B-cell lymphoma/leukemia 10 , CARD containing molecule enhancing NF-kB , CARD-containing apoptotic signaling protein , CARD-containing molecule enhancing NF-kappa-B , CARD-containing proapoptotic protein , CED-3/ICH-1 prodomain homologous E10-like regulator , cCARMEN , caspase-recruiting domain-containing protein , cellular homolog of vCARMEN , cellular-E10 , hCLAP , mammalian CARD-containing adapter molecule E10 , B-cell leukemia/lymphoma 10 , R-RCD1 , RCD , bcl-10 , B-cell lymophoma 10 protein , B-cell CLL/lymphoma 10 , B cell lymphoma/leukemia 10 , CARD-like apoptotic protein

8915 Homo sapiens
83477 Rattus norvegicus
424528 Gallus gallus
456984 Pan troglodytes
490183 Canis lupus familiaris
540824 Bos taurus
548494 Xenopus (Silurana) tropicalis
100125346 Sus scrofa
100223183 Taeniopygia guttata
12042 Mus musculus
100196227 Salmo salar
100729772 Cavia porcellus
101113372 Ovis aries
Selected quality suppliers for anti-BCL10 (BCL10) Antibodies
Did you look for something else?